CATHERINE BADIM: Open Payments
NPI 1518575232 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,883 in 109 payments from 16 companies in 2025. Trend: 2023 $470 · 2024 $1,386 · 2025 $1,883
Food & beverage: $1,833Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $297 |
| Janssen Biotech, Inc. | 12 | $246 |
| Madrigal Pharmaceuticals | 14 | $223 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $202 |
| GENZYME CORPORATION | 9 | $166 |
| PFIZER INC. | 9 | $155 |
| Ardelyx, Inc. | 8 | $143 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $107 |
| Regeneron Healthcare Solutions, Inc. | 5 | $96 |
| Lilly USA, LLC | 4 | $85 |
Products named: DUPIXENT, TREMFYA, REZDIFFRA, IBSRELA, RINVOQ, ENTYVIO, VELSIPITY, XIFAXAN.
Industry payments across NJ — which companies pay providers there.
